Europe races to placate pharma as Trump turns up the pressure
Tariff deals with the US have bought time but investment momentum is elsewhere. Pharmaceutical companies have long complained Europe spends too little on drugs. It took the arrival of Donald Trump — threatening steep tariffs and accusing European countries of “freeloading” on the US — for the warnings to register. In response to the threats, European governments raced to strike deals. The UK secured a zero tariff arrangement in return for higher spending on medicines and lower costs for drugmakers. Читать дальше...